Study of the Fed-Fast Pharmocokinetics and Bioequivalance of 300mg Capsules of Droxidopa

NCT01149629 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

24

Enrollment

INDUSTRY

Sponsor class

Conditions

Symptomatic Neurogenic Orthostatic Hypotension

Interventions

DRUG: Droxidopa
DRUG: Droxidopa
DRUG: Droxidopa

Sponsor

Chelsea Therapeutics